By Alex Philippidis

NEW YORK (GenomeWeb News) – Access to more of China's large patient populations and centralized health records, plus the ability to apply new technologies and expand on earlier joint projects, are among benefits foreseen by the Fred Hutchinson Cancer Research Center from the formal collaboration signed yesterday with the Chinese Center for Disease Control and Prevention.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.